EP3846816A4 - Neuroprotektive mittel zur behandlung von neurodegenerativen erkrankungen - Google Patents
Neuroprotektive mittel zur behandlung von neurodegenerativen erkrankungen Download PDFInfo
- Publication number
- EP3846816A4 EP3846816A4 EP19858466.6A EP19858466A EP3846816A4 EP 3846816 A4 EP3846816 A4 EP 3846816A4 EP 19858466 A EP19858466 A EP 19858466A EP 3846816 A4 EP3846816 A4 EP 3846816A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- treatment
- neurodegenerative diseases
- neuroprotective agents
- neuroprotective
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000004770 neurodegeneration Effects 0.000 title 1
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
- 239000004090 neuroprotective agent Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/124,974 US10874669B2 (en) | 2012-11-29 | 2018-09-07 | Neuroprotective agents for treatment of neurodegenerative diseases |
US16/154,301 US20190038622A1 (en) | 2012-11-29 | 2018-10-08 | Neuroprotective agents for treatment of neurodegenerative diseases |
PCT/US2019/049927 WO2020051435A1 (en) | 2018-09-07 | 2019-09-06 | Neuroprotective agents for treatment of neurodegenerative diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3846816A1 EP3846816A1 (de) | 2021-07-14 |
EP3846816A4 true EP3846816A4 (de) | 2022-08-17 |
Family
ID=69723262
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19858466.6A Pending EP3846816A4 (de) | 2018-09-07 | 2019-09-06 | Neuroprotektive mittel zur behandlung von neurodegenerativen erkrankungen |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3846816A4 (de) |
CA (1) | CA3111561A1 (de) |
WO (1) | WO2020051435A1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115724758A (zh) * | 2021-08-24 | 2023-03-03 | 杭州中美华东制药有限公司 | 喜树碱衍生物中间体及其合成方法和利用中间体合成喜树碱衍生物的方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2925755B1 (de) * | 2012-11-29 | 2021-09-08 | Wayne State University | Neuroprotektive mittel zur behandlung von neurodegenerativen erkrankungen |
-
2019
- 2019-09-06 CA CA3111561A patent/CA3111561A1/en active Pending
- 2019-09-06 WO PCT/US2019/049927 patent/WO2020051435A1/en unknown
- 2019-09-06 EP EP19858466.6A patent/EP3846816A4/de active Pending
Non-Patent Citations (1)
Title |
---|
No further relevant documents disclosed * |
Also Published As
Publication number | Publication date |
---|---|
EP3846816A1 (de) | 2021-07-14 |
CA3111561A1 (en) | 2020-03-12 |
WO2020051435A1 (en) | 2020-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL288523A (en) | Compounds for the treatment of pd-l1 diseases | |
EP3621973A4 (de) | Verbindungen zur vorbeugung und behandlung von erkrankungen und verwendung davon | |
EP3448851B8 (de) | Di-substituierte pyrazolverbindungen zur behandlung von krankheiten | |
EP3773629A4 (de) | Car-treg-basierte therapien zur behandlung von neurodegenerativen erkrankungen | |
EP3600286A4 (de) | Verbindungen und verfahren zur behandlung von parasitären erkrankungen | |
EP4045036A4 (de) | Heteroaryl-biphenylamide zur behandlung von pd-l1-erkrankungen | |
EP3856243A4 (de) | Verfahren zur behandlung neurodegenerativer erkrankungen | |
EP4045037A4 (de) | Heteroaryl-biphenyl-amine zur behandlung von pd-l1-erkrankungen | |
EP3805216A4 (de) | Verbindungen zur behandlung oder vorbeugung von lebererkrankungen | |
EP3947390A4 (de) | Zusammensetzungen und verfahren zur ihrer verwendung für die behandlung von neurodegenerativer und mitochondrialer erkrankung | |
EP3573617A4 (de) | Therapeutikum für lebererkrankungen | |
EP3634394A4 (de) | Zusammensetzungen zur behandlung von neurodegenerativen erkrankungen | |
EP3619204A4 (de) | Verbindungen zur behandlung von atemwegserkrankungen | |
GB201714307D0 (en) | Treatment of neurodegenerative diseases | |
IL273929A (en) | Therapeutic agents for neurodegenerative diseases | |
EP3862012A4 (de) | Therapeutikum für neurodegenerative erkrankungen | |
EP3897602A4 (de) | Pharmazeutische kombinationen zur behandlung von krebs | |
EP3283457A4 (de) | Verbindungen und verfahren zur behandlung von neurodegenerativen erkrankungen | |
EP3761982A4 (de) | Behandlung von demyelinisierungskrankheiten | |
EP3706867A4 (de) | Therapeutische kombination zur behandlung von cerebellärer ataxie | |
EP3846816A4 (de) | Neuroprotektive mittel zur behandlung von neurodegenerativen erkrankungen | |
EP3672583A4 (de) | Zusammensetzungen und verfahren zur behandlung neurodegenerativer erkrankungen | |
EP3534954A4 (de) | Verbindungen zur behandlung von neurodegenerativen erkrankungen | |
GB201805100D0 (en) | Treatment of sarcopenic diseases | |
EP3755334A4 (de) | Behandlung von lebererkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20210308 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 25/16 20060101ALI20220408BHEP Ipc: A61P 25/28 20060101ALI20220408BHEP Ipc: A61K 31/4184 20060101ALI20220408BHEP Ipc: A61K 31/137 20060101ALI20220408BHEP Ipc: A61K 31/428 20060101ALI20220408BHEP Ipc: A61K 31/496 20060101ALI20220408BHEP Ipc: A61K 31/495 20060101AFI20220408BHEP |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Free format text: PREVIOUS MAIN CLASS: A61K0031497000 Ipc: A61K0031495000 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20220715 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 25/16 20060101ALI20220711BHEP Ipc: A61P 25/28 20060101ALI20220711BHEP Ipc: A61K 31/4184 20060101ALI20220711BHEP Ipc: A61K 31/137 20060101ALI20220711BHEP Ipc: A61K 31/428 20060101ALI20220711BHEP Ipc: A61K 31/496 20060101ALI20220711BHEP Ipc: A61K 31/495 20060101AFI20220711BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20240514 |